awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51425302-23FDB139-4523-4F1F-A54B-536EDCFA626D
Q51425302-23FDB139-4523-4F1F-A54B-536EDCFA626D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51425302-23FDB139-4523-4F1F-A54B-536EDCFA626D
A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer.
P2860
Q51425302-23FDB139-4523-4F1F-A54B-536EDCFA626D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51425302-23FDB139-4523-4F1F-A54B-536EDCFA626D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
71e6fd0c88e9bfbe53ec327bd095ca1d93bc29ea
P2860
Phase III study of doxorubicin/cyclophosphamide with concomitant versus sequential docetaxel as adjuvant treatment in patients with human epidermal growth factor receptor 2-normal, node-positive breast cancer: BCIRG-005 trial.